Cleared Traditional

K100840 - EMBO PLUS EMBOLECTOMY CATHETER

K100840 is an FDA 510(k) clearance for EMBO PLUS EMBOLECTOMY CATHETER, manufactured by Hotspur Technologies. The device is a Class 2 Cardiovascular device with product code DXE cleared through the Traditional 510(k) pathway after a 110-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
110d
Days
Class 2
Risk

K100840 is an FDA 510(k) clearance for the EMBO PLUS EMBOLECTOMY CATHETER. Classified as Catheter, Embolectomy (product code DXE), Class II - Special Controls.

Submitted by Hotspur Technologies (Mountain View, US). The FDA issued a Cleared decision on July 12, 2010 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5150 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Hotspur Technologies devices

FDA 510(k) Submission Details - K100840

510(k) Number K100840 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 2010
Decision Date July 12, 2010
Days to Decision 110 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 125d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXE Device Classification - Class 2, Special Controls

Product Code DXE Catheter, Embolectomy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXE Catheter, Embolectomy

All 43
Devices cleared under the same product code (DXE) and FDA review panel - the closest regulatory comparables to K100840.
Bunegin-Albin Air Aspiration Set
K163031 · Cook Incorporated · Jul 2017
Needle's Eye Snare Retrieval Set - 54cm
K163353 · Cook Incorporated · Jul 2017
Export Advance Aspiration Catheter
K152335 · Medtronic, Inc. · Sep 2015
MEDTRONIC EXPORT AP CATHETER
K081573 · Medtronic Vascular · Jun 2008
OVER THE WIRE EMBOLECTOMY CATHETER, MODEL 2302
K022145 · LeMaitre Vascular, Inc. · Jan 2003
MODIFICATION TO ATRIUM MEDICAL CORPORATION CLEARWAY PTFE BALLOON CATHETER
K020634 · Atrium Medical Corp. · May 2002